| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 156 | 733 | 846 | | Cost of Revenue | 30 | 297 | 307 | | | Gross Profit | 126 | 436 | 539 | | | Operating Expenses | | Research Development | 2,926 | 1,613 | 1,678 | | Selling General and Administrative | 5,031 | 3,828 | 4,320 | | Non Recurring | 1,318 |
-
|
-
| | Others | 84 | 266 | 758 | | | | Total Operating Expenses | 9,360 |
-
|
-
| | | | Operating Income or Loss | (9,234) | (5,271) | (6,216) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 540 | 853 | 601 | | Earnings Before Interest And Taxes | (8,694) | (4,418) | (5,615) | | Interest Expense | 51 |
-
|
-
| | Income Before Tax | (8,745) | (4,418) | (5,615) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,745) | (4,418) | (5,615) | | | Non-recurring Events | | Discontinued Operations | (457) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,202) | (4,418) | (5,615) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,202) | ($4,418) | ($5,615) |
|
1.52% Nasdaq 
Income Statement
